rs1320543506
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014625.4(NPHS2):c.104dupG(p.Arg36ProfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000134 in 1,492,432 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position has been classified as Likely pathogenic. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014625.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- nephrotic syndrome, type 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Myriad Women’s Health, Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina, G2P
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHS2 | ENST00000367615.9 | c.104dupG | p.Arg36ProfsTer34 | frameshift_variant | Exon 1 of 8 | 1 | NM_014625.4 | ENSP00000356587.4 | ||
| NPHS2 | ENST00000367616.4 | c.104dupG | p.Arg36ProfsTer34 | frameshift_variant | Exon 1 of 7 | 1 | ENSP00000356588.4 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151828Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 90220 AF XY: 0.00
GnomAD4 exome AF: 7.46e-7 AC: 1AN: 1340604Hom.: 0 Cov.: 31 AF XY: 0.00000151 AC XY: 1AN XY: 660880 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151828Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74134 show subpopulations
ClinVar
Submissions by phenotype
Nephrotic syndrome, type 2 Pathogenic:4
Variant summary: NPHS2 c.104dupG (p.Arg36ProfsX34) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 90220 control chromosomes. c.104dupG has been reported in the literature in individuals affected with Nephrotic Syndrome, Type 2 (example, Boute_2000, Machuca_2010, Giglio_2015). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
not provided Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Arg36Profs*34) in the NPHS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS2 are known to be pathogenic (PMID: 10742096, 14701729, 15253708, 23595123). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with nephrotic syndrome (PMID: 10742096). ClinVar contains an entry for this variant (Variation ID: 447876). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at